We are live on ! Find out more
MA

Montag & Associates Portfolio holdings

AUM $2.15B
1-Year Est. Return 20.86%
This Fund
S&P 500
This Quarter Est. Return
-12.61%
1 Year Est. Return
+20.86%
3 Year Est. Return
+68%
5 Year Est. Return
+82.09%
10 Year Est. Return
+321.81%
AUM
$1.55B
AUM Growth
-$338M
Cap. Flow
-$81.1M
Cap. Flow %
-5.25%
Top 10 Hldgs %
30.28%
Holding
871
New
14
Increased
114
Reduced
237
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 12.78%
2 Healthcare 9.97%
3 Financials 9.37%
4 Consumer Discretionary 7.32%
5 Consumer Staples 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLK icon
26
State Street Technology Select Sector SPDR ETF
XLK
$115B
$12M 0.78%
188,494
+100,310
+114% +$6.99M
PG icon
27
Procter & Gamble
PG
$336B
$11.9M 0.77%
82,797
+1,729
+2% +$260K
VB icon
28
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$11.8M 0.77%
67,218
-20,449
-23% -$3.95M
RSP icon
29
Invesco S&P 500 Equal Weight ETF
RSP
$97B
$11.8M 0.76%
87,656
+4,897
+6% +$716K
EFX icon
30
Equifax
EFX
$20.3B
$11.3M 0.73%
61,670
-360
-0.6% -$72K
JPM icon
31
JPMorgan Chase
JPM
$935B
$11.1M 0.72%
98,454
+740
+0.8% +$91.7K
VO icon
32
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$10.9M 0.7%
220,700
-2,488
-1% -$134K
BSCN
33
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$10.5M 0.68%
501,914
+51,275
+11% +$1.08M
ABBV icon
34
AbbVie
ABBV
$443B
$10M 0.65%
65,336
-2,199
-3% -$336K
EW icon
35
Edwards Lifesciences
EW
$49.6B
$9.98M 0.65%
105,001
-457
-0.4% -$47.3K
CVX icon
36
Chevron
CVX
$392B
$9.88M 0.64%
68,249
+2,525
+4% +$417K
WMT icon
37
Walmart Inc
WMT
$885B
$9.71M 0.63%
239,691
-2,850
-1% -$131K
IJR icon
38
iShares Core S&P Small-Cap ETF
IJR
$109B
$9.5M 0.61%
102,848
-19,390
-16% -$1.93M
VDE icon
39
Vanguard Energy ETF
VDE
$10.1B
$9.24M 0.6%
92,878
+7,506
+9% +$840K
QCOM icon
40
Qualcomm
QCOM
$155B
$9.18M 0.59%
71,863
-18,081
-20% -$2.46M
GPC icon
41
Genuine Parts
GPC
$17.1B
$8.97M 0.58%
67,006
-1,288
-2% -$171K
IWF icon
42
iShares Russell 1000 Growth ETF
IWF
$121B
$8.79M 0.57%
160,724
+1,412
+0.9% +$84.8K
BSCO
43
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$8.7M 0.56%
419,241
+83,617
+25% +$1.75M
GS icon
44
Goldman Sachs
GS
$300B
$8.38M 0.54%
28,207
-5,455
-16% -$1.7M
BSCP
45
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$8.36M 0.54%
408,740
+115,672
+39% +$2.38M
MA icon
46
Mastercard
MA
$506B
$8.35M 0.54%
26,458
-1,053
-4% -$363K
IWD icon
47
iShares Russell 1000 Value ETF
IWD
$82.2B
$7.83M 0.51%
54,013
+4,667
+9% +$730K
TMO icon
48
Thermo Fisher Scientific
TMO
$213B
$7.78M 0.5%
14,308
-1,934
-12% -$1.06M
CPRT icon
49
Copart
CPRT
$27B
$7.59M 0.49%
279,260
MCD icon
50
McDonald's
MCD
$192B
$7.58M 0.49%
30,703
+119
+0.4% +$29.3K

Similar funds

Montag & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Montag & Associates held 871 positions worth $1.55B, down 18% from $1.88B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Montag & Associates withdrew a net $81.1M in Q2 2022, closing 19 positions and reducing 237 holdings. Its most notable exit was Amedisys, an estimated $2.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Montag & Associates opened a new position in iShares iBonds Dec 2023 Term Treasury ETF worth $1.76M.

  • Montag & Associates's largest Q2 2022 buy was iShares iBonds Dec 2023 Term Treasury ETF: 70,553 shares worth $1.76M.
  • Montag & Associates added most to JPMorgan Ultra-Short Income ETF in Q2 2022, an estimated $13.1M increase.
  • Montag & Associates's biggest Q2 2022 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $19M.
  • Montag & Associates fully exited Amedisys in Q2 2022, selling an estimated $2.86M.
  • Montag & Associates's ten largest holdings make up 30% of its $1.55B portfolio in Q2 2022.
  • Montag & Associates opened 14 new positions and closed 19 in Q2 2022.
  • Montag & Associates's portfolio value fell 18% quarter-over-quarter to $1.55B.

Based on Montag & Associates's 13F filing for Q2 2022, filed 10 Aug 2022.